Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Journal of Pharmacological Sciences|July 18, 2009
Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: overview of the pathophysiology of atopic dermatitisTadashi Terui
Journal of Dermatological Science|March 24, 2020
Palmoplantar pustulosis: Current understanding of disease definition and pathomechanismMasamoto Murakami, Tadashi Terui
Dermatology (Basel, Switzerland)|October 6, 2005
Localization of IL-8 and complement components in lesional skin of psoriasis vulgaris and pustulosis palmaris et plantarisMaki Ozawa, Tadashi Terui, Hachiro Tagami
The Journal of Dermatology|October 14, 2020
Guselkumab improves joint pain in patients with pustulotic arthro-osteitis: A retrospective pilot studyNatsumi Ikumi, Hideki Fujita, Tadashi Terui
The Journal of Dermatology|October 7, 2024
Spesolimab, the first-in-class anti-IL-36R antibody: From bench to clinicAkimichi Morita, Yukari Okubo, Shinichi Imafuku, et al.
European Journal of Dermatology : EJD|November 5, 2010
A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitisKoremasa Hayama, Toru Inadomi, Daisuke Fujisawa, et al.
The Journal of Dermatology|May 23, 2020
Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countriesKoremasa Hayama, Hideki Fujita, Takashi Hashimoto, et al.
International Archives of Allergy and Immunology|June 5, 2010
Prolonged culture of mast cells with high-glucose medium enhances the Fc epsilon RI-mediated degranulation response and leukotriene C4 productionYuko Kitahata, Satoshi Nunomura, Tadashi Terui, et al.
Pediatric Dermatology|August 27, 2010
A case of cutaneous mastocytosis in a child with prominent Langerhans cell infiltrationJuniku Mitsuya, Hiroyuki Hara, Naozumi Fukuda, et al.
The Journal of Dermatology|August 28, 2021
Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 studyYukari Okubo, Hitomi Morishima, Richuan Zheng, et al.
Pageof 9